发明公开
- 专利标题： ALKYLCARBAMAT-SUBSTITUIERTE BUTYROLACTONE ALS LIPASE-INHIBITOREN
- 专利标题（英）： Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors
- 专利标题（中）： 烷基取代的氨基甲丁内酯AS脂酶抑制剂
-
申请号： EP05716736.3申请日： 2005-02-18
-
公开(公告)号： EP1751126A1公开(公告)日： 2007-02-14
- 发明人: WALDECK, Harald , ANTEL, Jochen , EYTING, Sabine , WURL, Michael , GREGORY, Peter-Colin , WOLFF, Maike
- 申请人： Solvay Pharmaceuticals GmbH
- 申请人地址： Hans-Böckler-Allee 20 30173 Hannover DE
- 专利权人： Solvay Pharmaceuticals GmbH
- 当前专利权人： Solvay Pharmaceuticals GmbH
- 当前专利权人地址： Hans-Böckler-Allee 20 30173 Hannover DE
- 代理机构： Gosmann, Martin
- 优先权： DE102004009076 20040223
- 国际公布： WO2005080366 20050901
- 主分类号： C07D305/12
- IPC分类号： C07D305/12 ; A61K31/335 ; A61P3/00
摘要：
The invention relates to substituted β-lactones (oxetanones) of general formula (I), in which R1, R2 and n have the meanings cited in the description, and to medicaments, which contain these compounds and which have a pancreas lipase-inhibiting effect. The invention also relates to a method for producing the compounds of formula (I) and to intermediate products of this method.
公开/授权文献
信息查询
